Overview
Rare genetic respiratory disease (Orphanet code 156610) is a broad category that encompasses uncommon inherited conditions primarily affecting the lungs and airways. These diseases are caused by changes (mutations) in genes that play important roles in how the lungs develop, function, or protect themselves. Because this Orphanet code refers to a general grouping rather than a single well-defined condition, the specific symptoms, severity, and course of illness can vary widely depending on the exact underlying genetic cause. People with rare genetic respiratory diseases may experience chronic breathing difficulties, recurrent lung infections, progressive lung damage, and reduced ability to exercise or perform daily activities. Some forms appear at birth or in early childhood, while others may not become apparent until later in life. The lungs may have trouble clearing mucus, maintaining proper gas exchange, or developing normally. Treatment depends on the specific diagnosis within this group and typically focuses on managing symptoms, preventing infections, and preserving lung function. Options may include inhaled medications, airway clearance techniques, supplemental oxygen, anti-inflammatory drugs, and in severe cases, lung transplantation. Genetic testing has become increasingly important for identifying the precise cause, which can guide treatment decisions and help families understand the risk of passing the condition to future generations. Research into gene therapies and targeted treatments is ongoing for many conditions in this category.
Key symptoms:
Chronic coughShortness of breathRecurrent lung infectionsWheezingDifficulty breathing during exerciseExcess mucus productionLow oxygen levels in the bloodFailure to thrive in childrenChest tightnessRapid breathingClubbing of the fingers or toesFatigue and low energy
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
4 eventsUniversity of Texas Southwestern Medical Center — NA
Indiana University — PHASE4
Karolinska Institutet — NA
University of Oulu — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Rare genetic respiratory disease.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare genetic respiratory disease.
Community
No community posts yet. Be the first to share your experience with Rare genetic respiratory disease.
Start the conversation →Latest news about Rare genetic respiratory disease
No recent news articles for Rare genetic respiratory disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact genetic cause of my (or my child's) respiratory disease?,How will this condition likely progress over time?,What daily treatments and therapies are recommended?,Are there any clinical trials or new treatments being studied for this condition?,Should other family members be tested for this genetic change?,When should I seek emergency care for breathing problems?,Is lung transplantation something we may need to consider in the future?
Common questions about Rare genetic respiratory disease
What is Rare genetic respiratory disease?
Rare genetic respiratory disease (Orphanet code 156610) is a broad category that encompasses uncommon inherited conditions primarily affecting the lungs and airways. These diseases are caused by changes (mutations) in genes that play important roles in how the lungs develop, function, or protect themselves. Because this Orphanet code refers to a general grouping rather than a single well-defined condition, the specific symptoms, severity, and course of illness can vary widely depending on the exact underlying genetic cause. People with rare genetic respiratory diseases may experience chronic
Are there clinical trials for Rare genetic respiratory disease?
Yes — 3 recruiting clinical trials are currently listed for Rare genetic respiratory disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Rare genetic respiratory disease?
13 specialists and care centers treating Rare genetic respiratory disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.